Quality comes from production
Release time:
2022-12-22
"to do high-quality medicine, for the benefit of human society" has always been our peak pharmaceutical enterprise purpose. The development of the pharmaceutical industry is inseparable from the diversification of drugs, but also inseparable from the quality of drugs.
quality is the basis of everything, no quality, brand, development, competition is impossible. So where does the quality come from? Quality is reflected in the drug. Some people may say that the quality of drugs is tested, and the inspection can distinguish between qualified and unqualified, but if you do not test, the quality is already in the drugs, and it is impossible to say that the quality attributes of untested products no longer exist. Quality comes from the process of drug design, production and manufacturing, and inspection plays a gatekeeper role. Therefore, quality comes from production.
Quality is an attitude, and the quality of medicines is fundamental to the survival of an enterprise. To ensure the quality of drugs, we need to regard ourselves as a member of the enterprise, deeply realize that we are a part of the enterprise, and the development of the enterprise can drive our development. In our work, every subtle link requires our serious and dedicated work. If the work is not careful, the operation is not standardized, and the cleaning is not in place, it may cause quality accidents. A wisp of flying flowers, a defect, a carelessness, are all small problems, but it is these details that determine success or failure. Take the production of our comprehensive preparation workshop as an example. The birth of a piece of medicine requires the issuance of production instructions. Weighing personnel weigh according to the production instructions. Granulating personnel check the material information and then feed and granulate. Tabletting personnel check the material information produced by granulation posts and then press tablets according to process requirements. Drugs with coating requirements are pressed and coated. Aluminum plastic personnel receive plain tablets with correct information, adjust the production batch number and validity period according to the production instructions, and then produce it through the pillow package outsourcing line after it is correct. These posts are linked and linked layer by layer. If any link is slightly neglected, for example, the weighing personnel forget to peel when weighing, it will lead to feeding errors. If the granulation and tabletting personnel do not operate according to the process requirements, the drugs produced will be unqualified, and even if a certain clearing is not in place, it will also lead to unqualified drug quality. Therefore, quality is closely related to our every operation and every tour. Only when we strictly control the quality and act in strict accordance with the operating procedures, can we prevent the slightest failure and nip in the bud. This requires us to keep our quality awareness in mind and strictly demand ourselves in our work.
Quality is the foundation of an enterprise, and quality is the life of an enterprise. Only by putting the emphasis on quality in the first place in the work of the entire enterprise, being meticulous, striving for perfection, and always maintaining high quality and efficiency. Only in this way can we be in an invincible position in today's fierce competition. (Fuck the inscription)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page